Open access · CC-BY
via OpenAlex
Biochemical Markers in Alzheimer’s Disease
Alessandro Rabbito, Maciej Dulewicz, Agnieszka Kulczyńska‐Przybik, Barbara Mroczko
International Journal of Molecular Sciences · 2020 · ▲ 104 citations
Abstract
Alzheimer's disease (AD) is one of the most frequent neurodegenerative diseases affecting more than 35 million people in the world, and its incidence is estimated to triple by 2050. Alzheimer's disease is an age-related disease characterized by the progressive loss of memory and cognitive function, caused by the unstoppable neurodegeneration and brain atrophy. Current AD treatments only relieve the symptoms. The first molecular signs of the disease identified decades ago and were related to the tau neurofibrillary tangles and the β amyloid plaques. Despite the considerable progress in the diagnostic field, there is no certain knowledge of the specific biomarkers reflecting molecular mechanisms that trigger the symptoms of the disease. Therefore, there is an enormous need to find biomarkers useful for early diagnosis, before the first symptoms appear, and develop new therapeutic targets, which would guarantee improving patients' quality of life. Researchers from all around the world are looking for biomarkers that can be identified in different biological fluids such as plasma, serum, and cerebrospinal fluid, specific for Alzheimer's disease. In this review, we would like to resume some of the most interesting discovery in pathological mechanisms underlying Alzheimer's disease and promising biomarkers.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms21061989
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Rabbito, A., Dulewicz, M., Kulczyńska‐Przybik, A., & Mroczko, B. (2020). Biochemical Markers in Alzheimer’s Disease. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms21061989
Vancouver
Rabbito A, Dulewicz M, Kulczyńska‐Przybik A, Mroczko B. Biochemical Markers in Alzheimer’s Disease. International Journal of Molecular Sciences. 2020. doi:10.3390/ijms21061989.
BibTeX
@article{alessandro2020Bioche,
title = {Biochemical Markers in Alzheimer’s Disease},
author = {Alessandro Rabbito and Maciej Dulewicz and Agnieszka Kulczyńska‐Przybik and Barbara Mroczko},
journal = {International Journal of Molecular Sciences},
year = {2020},
doi = {10.3390/ijms21061989},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Taichung Veterans General Hospital 2012
Open access · US-GOV
Department of Psychiatry, Taichung Veterans General Hospital
Molecular Neurodegeneration 2016
Open access · CC-BY
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
Neurobiology of aging 2027
Citation only
The effect of neurodegeneration on ultrasonic vocalisations (USV) and their neuronal substrates in mice and rats: A systematic review.
Qatar Foundation Annual Research Conference (ARC) 2016
Citation only
Alpha-Synuclein Oligomers as a Biomarker Candidate for Parkinson's Disease and Disorders
Neuropeptides 2018
Citation only
Sirtuin 1 and Alzheimer's disease: An up-to-date review
Nature Reviews Rheumatology 2018
Open access · OA